Abstract

Amprius Technologies Operating Inc will report its quarterly results on May 7, 2026 Pre-Market; this preview distills last quarter’s metrics, current-quarter forecasts on revenue, margins, net income and EPS, recent order flow developments, and the dominant institutional opinions shaping expectations.

Market Forecast

Based on current projections, Amprius Technologies Operating Inc is expected to deliver revenue of 25.72 million US dollars this quarter, implying a 201.93% year-over-year increase; EPS is forecast at -0.02, reflecting a 73.39% year-over-year improvement, and EBIT is estimated at -3.71 million US dollars, an improvement of 65.32% year over year. Forecast margin data for the quarter is not available; the focus will be on whether gross profitability can hold near the recent 23.65% level while the company narrows losses in line with the projected EPS and EBIT improvements. The core revenue engine remains product sales to customers, which historically account for about 98.49% of the revenue mix; if the mix profile remains consistent, core revenue would approximate 25.33 million US dollars at the company’s projected top line, with the year-over-year trajectory closely tracking the company-wide 201.93% growth outlook. The most promising near-term growth vector is the SiCore cylindrical cell line for light electric vehicles, supported by a new 21.00 million US dollar purchase order won in March; timing of revenue recognition may span multiple quarters, but the order value is substantive relative to the projected quarterly run-rate and underscores an elevated year-over-year growth setup for that product line.

Last Quarter Review

In the previous quarter, Amprius Technologies Operating Inc generated 25.23 million US dollars in revenue (up 137.36% year over year), a gross profit margin of 23.65%, a GAAP net loss attributable to the parent company of 24.39 million US dollars, a net profit margin of -96.66%, and EPS of -0.18 (down 80.00% year over year). Revenue exceeded projections by 2.26 million US dollars, but profitability deteriorated as the quarter-on-quarter change in net profit was -526.70%, reflecting elevated operating investment and scale-up costs versus the revenue base. From a business mix standpoint, customer-driven product sales represented about 98.49% of the quarter’s revenue, translating to approximately 24.86 million US dollars, while government-related subsidies contributed about 0.38 million US dollars; the sharp 137.36% year-over-year revenue increase indicates substantially higher shipment volumes and program wins feeding through to the top line despite persistent operating losses.

Current Quarter Outlook

Main business: customer product revenue and margin trajectory

The core of this quarter’s story is whether product revenue to customers can sustain momentum while protecting unit economics. With total revenue projected at 25.72 million US dollars and customer sales historically accounting for 98.49% of the mix, the implied core revenue of roughly 25.33 million US dollars represents a continuation of last quarter’s scale. The previous quarter’s gross profit margin of 23.65% provides a starting point for assessing operating leverage; the market will scrutinize whether the company can maintain a similar margin as it absorbs higher production volumes and manages start-up and scaling costs. An improvement in EPS to an estimated -0.02, alongside an EBIT estimate of -3.71 million US dollars, signals progress toward narrowing losses even without explicit margin guidance, provided that gross profit scales at least proportionally with revenue. Execution in this context means predictable fulfillment, stable pricing, and incremental cost containment to prevent gross margin compression as volumes rise. With revenue growth momentum at triple-digit rates year over year, outsized operating expense growth can still dilute progress at the EPS line if not carefully paced; investors will parse operating expense run-rate and incremental gross profit generation to gauge whether the path to profitability is steepening or flattening. The comparison point from last quarter—net profit margin of -96.66%—sets a low base, so even modest improvements in contribution margin and operating efficiency can translate into visible gains at the EPS level, especially given the small absolute EPS figure forecast for this quarter. The key to aligning the forecasted EPS improvement with the revenue growth profile is managing production yields and supply-chain inputs tightly enough to preserve recent gross profit margin levels.

Most promising business: SiCore cylindrical cells and light electric vehicle orders

A major incremental growth catalyst is the SiCore cylindrical cell line, where the company recently secured a 21.00 million US dollar purchase order from a new electric mobility customer for use in scooters, three-wheelers, and motorcycles. Relative to the company’s projected quarterly revenue of 25.72 million US dollars, the order size is substantive and, depending on delivery and acceptance milestones, could support revenue recognition across multiple quarters starting as early as the current quarter. The order underscores accelerating commercial demand for this product line and provides visibility to sustained shipment volume; it also has the potential to diversify the customer and application base within the company’s sales mix. Financially, the order’s size versus the quarterly revenue baseline suggests that even partial recognition can enhance utilization and mix. The degree of margin accretion will depend on production yields and contract pricing relative to historical costs embedded in the 23.65% gross margin from last quarter; efficient conversion and delivery schedules would help reinforce the forecasted improvements in EBIT and EPS. Should revenue recognition begin this quarter, it would provide near-term validation of the projection calling for a 201.93% year-over-year revenue increase, while enhancing backlog visibility for subsequent periods if shipments are staged. Conversely, any slippage in delivery timelines would not negate the order’s value but could shift recognition into later quarters, affecting short-term comparisons without altering the medium-term revenue trajectory.

Stock-price swing factors this quarter

Three variables are poised to drive share price reactions around the print. The first is the revenue outturn versus the 25.72 million US dollars projection; a repeat of last quarter’s revenue beat would be constructive, especially if accompanied by steady or improving gross margins against the recent 23.65% reference point. The second is the loss trajectory: with EPS expected at -0.02 and EBIT at -3.71 million US dollars, the market will monitor whether operating leverage materializes in line with the model, particularly in the context of last quarter’s net profit margin of -96.66%. A quantifiable narrowing of losses would indicate that top-line expansion is beginning to translate into bottom-line progress, a critical step for re-rating. The third swing factor is the cadence and conversion of recently announced orders, notably the 21.00 million US dollar SiCore purchase order. Evidence that shipments have commenced and revenue is being recognized this quarter can support sustained revisions to near-term revenue expectations and enhance visibility for the remainder of the year. Conversely, any commentary indicating delays in production or delivery could weigh on sentiment, even if the order book remains intact. Guidance updates that frame shipment timing, capital deployment, and the expected arc of gross margins will likely be as important as the reported numbers themselves, given the scale of the year-over-year growth expected this quarter.

Analyst Opinions

Across recent notes, institutional views skew decisively positive: bullish versus bearish opinions stand at 3:0. Cantor Fitzgerald reaffirmed a Buy rating with a 20.00 US dollars price target, Northland Securities maintained a Buy with a 20.00 US dollars price target, and B. Riley lifted its price target to 22.00 US dollars while keeping a Buy stance. The common thread across these opinions is confidence that revenue is scaling and the earnings trajectory is improving from a low base, consistent with the 201.93% year-over-year revenue increase and the 73.39% year-over-year EPS improvement embedded in this quarter’s forecasts. From a financial modeling perspective, the constructive stance is rooted in three observable dynamics. First, the company continues to translate program wins and order momentum into rapidly expanding top-line performance—proof evident in last quarter’s 137.36% year-over-year revenue growth and the ongoing projection for triple-digit year-over-year growth this quarter. Second, even absent explicit margin guidance, the forecast profile implies that operating leverage is beginning to assert itself: EBIT is projected to improve to -3.71 million US dollars with a 65.32% year-over-year improvement, while EPS is modeled to improve to -0.02 with a 73.39% year-over-year uplift. Third, the recently secured 21.00 million US dollar SiCore cylindrical cell order is large relative to the company’s quarterly revenue scale, providing tangible support for forward revenue estimates and lending credibility to assumptions about shipment cadence and backlog conversion. Analysts emphasizing Buy ratings also point to the importance of near-term execution milestones in connecting order flow to recognized revenue and gross profit. The recent quarter’s 23.65% gross margin offers a useful yardstick; maintaining or expanding around that level while hitting the revenue guide would validate the premise that product shipments can scale without undue margin degradation. Given last quarter’s revenue beat of 2.26 million US dollars over projections, there is precedent for the company to outperform top-line expectations if fulfillment timing aligns favorably within the quarter. At the same time, the large negative net profit margin last quarter (-96.66%) and the -526.70% quarter-on-quarter swing in net profit emphasize how sensitive the bottom line is to cost absorption and scale effects; progress here is what Buy-rated analysts appear to expect, and it will likely determine whether the share price reaction is sustained. Putting these strands together, the bullish majority view anticipates that this quarter can demonstrate continued revenue scale and measurable, if incremental, improvement in losses, with additional support from new order activity that underpins the next legs of growth. A print and update that confirm revenue near 25.72 million US dollars, an EPS result tracking toward -0.02, and clear commentary on the initiation and timing of SiCore cylindrical cell shipments would align well with those expectations. The tone and specificity of management’s outlook on shipment cadence and gross margin drivers should frame whether models for the second half of 2026 remain intact or drift, but as it stands, the institutional consensus expects the company to advance along the projected path of strong year-over-year expansion and improving operating metrics this quarter.